Investigational Site Number :0320002

Capital Federal, Buenos Aires 1012

0 studies enrolling now · 2 studies all time

What they study most

Non-relapsing Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed